{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:04:09Z","timestamp":1782482649280,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11596-023-2740-7","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T14:02:36Z","timestamp":1684936956000},"page":"623-630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Establishment of FAP-overexpressing Cells for FAP-targeted Theranostics"],"prefix":"10.1007","volume":"43","author":[{"given":"Hui-ru","family":"Jian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-hao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-shuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-xu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-qing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"issue":"16","key":"2740_CR1","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC. The tumor microenvironment. Curr Biol, 2020,30(16):R921\u2013R925","journal-title":"Curr Biol"},{"issue":"4","key":"2740_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/ijms20040840","volume":"20","author":"C Roma-Rodrigues","year":"2019","unstructured":"Roma-Rodrigues C, Mendes R, Baptista PV, et al. Targeting Tumor Microenvironment for Cancer Therapy. Int J Mol Sci, 2019,20(4):840","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2740_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13058-016-0740-2","volume":"18","author":"KM Bussard","year":"2016","unstructured":"Bussard KM, Mutkus L, Stumpf K, et al. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res, 2016,18(1):84","journal-title":"Breast Cancer Res"},{"issue":"2","key":"2740_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2967\/jnumed.120.244806","volume":"62","author":"A Altmann","year":"2021","unstructured":"Altmann A, Haberkorn U, Siveke J. The Latest Developments in Imaging of Fibroblast Activation Protein. J Nucl Med, 2021,62(2):160\u2013167","journal-title":"J Nucl Med"},{"issue":"4","key":"2740_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ijc.32193","volume":"146","author":"M Nurmik","year":"2020","unstructured":"Nurmik M, Ullmann P, Rodriguez F, et al. In search of definitions: Cancer-associated fibroblasts and their markers. Int J Cancer, 2020,146(4):895\u2013905","journal-title":"Int J Cancer"},{"issue":"9","key":"2740_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1101\/gad.279737.116","volume":"30","author":"P Gascard","year":"2016","unstructured":"Gascard P, Tlsty TD. Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. Genes Dev, 2016,30(9):1002\u20131019","journal-title":"Genes Dev"},{"issue":"1","key":"2740_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/hep.32099","volume":"75","author":"Y Lin","year":"2022","unstructured":"Lin Y, Cai Q, Chen Y, et al. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase. Hepatology, 2022,75(1):28\u201342","journal-title":"Hepatology"},{"issue":"1","key":"2740_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40364-020-00245-w","volume":"8","author":"C Han","year":"2020","unstructured":"Han C, Liu T, Yin R. Biomarkers for cancer-associated fibroblasts. Biomark Res, 2020,8(1):64","journal-title":"Biomark Res"},{"issue":"4","key":"2740_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00403-014-1456-8","volume":"306","author":"J El Khoury","year":"2014","unstructured":"El Khoury J, Kurban M, Kibbi AG, et al. Fibroblast-activation protein: valuable marker of cutaneous epithelial malignancy. Arch Dermatol Res, 2014,306 (4):359\u2013365","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"2740_CR10","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2174\/156652412803833607","volume":"12","author":"M Jacob","year":"2012","unstructured":"Jacob M, Chang L, Pur\u00e9 E. Fibroblast activation protein in remodeling tissues. Curr Mol Med, 2012,12(10):1220\u20131243","journal-title":"Curr Mol Med"},{"issue":"10","key":"2740_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/14728222.2017.1370455","volume":"21","author":"L Juillerat-Jeanneret","year":"2017","unstructured":"Juillerat-Jeanneret L, Tafelmeyer P, Golshayan D. Fibroblast activation protein-alpha in fibrogenic disorders and cancer: more than a prolyl-specific peptidase? Expert Opin Ther Targets, 2017,21(10):977\u2013991","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"2740_CR12","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","volume":"39","author":"AA Fitzgerald","year":"2020","unstructured":"Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev, 2020,39(3):783\u2013803","journal-title":"Cancer Metastasis Rev"},{"issue":"32","key":"2740_CR13","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","volume":"37","author":"E Pur\u00e9","year":"2018","unstructured":"Pur\u00e9 E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene, 2018,37(32):4343\u20134357","journal-title":"Oncogene"},{"issue":"5\u20136","key":"2740_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","volume":"8","author":"EJ Hamson","year":"2014","unstructured":"Hamson EJ, Keane FM, Tholen S, et al. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteomics Clin Appl, 2014,8(5\u20136):454\u2013463","journal-title":"Proteomics Clin Appl"},{"issue":"8","key":"2740_CR15","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/j.1742-4658.2011.08051.x","volume":"278","author":"FM Keane","year":"2011","unstructured":"Keane FM, Nadvi NA, Yao TW, et al. Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-\u03b1. Febs j, 2011,278(8):1316\u20131332","journal-title":"Febs j"},{"issue":"8","key":"2740_CR16","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1021\/acsmedchemlett.9b00191","volume":"10","author":"A De Decker","year":"2019","unstructured":"De Decker A, Vliegen G, Van Rompaey D, et al. Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP). ACS Med Chem Lett, 2019,10(8):1173\u20131179","journal-title":"ACS Med Chem Lett"},{"issue":"4","key":"2740_CR17","doi-asserted-by":"publisher","first-page":"e1155","DOI":"10.1038\/cddis.2014.122","volume":"5","author":"H Wang","year":"2014","unstructured":"Wang H, Wu Q, Liu Z, et al. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN\/PI3K\/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death Dis, 2014,5(4):e1155","journal-title":"Cell Death Dis"},{"key":"2740_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2121-15-16","volume":"15","author":"J Jia","year":"2014","unstructured":"Jia J, Martin TA, Ye L, et al. FAP-\u03b1 (Fibroblast activation protein-\u03b1) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway. BMC Cell Biol, 2014,15:16","journal-title":"BMC Cell Biol"},{"issue":"9","key":"2740_CR19","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1016\/j.apsb.2021.03.016","volume":"11","author":"X Ning","year":"2021","unstructured":"Ning X, Wiraja C, Chew WTS, et al. Transdermal delivery of Chinese herbal medicine extract using dissolvable microneedles for hypertrophic scar treatment. Acta Pharm Sin B, 2021,11(9):2937\u20132944","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"2740_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2741\/4706","volume":"24","author":"AJ Lay","year":"2019","unstructured":"Lay AJ, Zhang HE, Mccaughan GW, et al. Fibroblast activation protein in liver fibrosis. Front Biosci (Landmark Ed), 2019,24(1):1\u201317","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"4","key":"2740_CR21","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/cvr\/cvaa142","volume":"117","author":"S Stein","year":"2021","unstructured":"Stein S, Weber J, Nusser-Stein S, et al. Deletion of fibroblast activation protein provides atheroprotection. Cardiovasc Res, 2021,117(4):1060\u20131069","journal-title":"Cardiovasc Res"},{"issue":"3","key":"2740_CR22","first-page":"338","volume":"20","author":"MJ Mousavi","year":"2021","unstructured":"Mousavi MJ, Farhadi E, Vodjgani M, et al. Role of Fibroblast Activation Protein Alpha in Fibroblast-like Synoviocytes of Rheumatoid Arthritis. Iran J Allergy Asthma Immunol, 2021,20(3):338\u2013349","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"6","key":"2740_CR23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, et al. (68)Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer. J Nucl Med, 2019,60(6):801\u2013805","journal-title":"J Nucl Med"},{"issue":"8","key":"2740_CR24","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2967\/jnumed.119.236786","volume":"61","author":"C Meyer","year":"2020","unstructured":"Meyer C, Dahlbom M, Lindner T, et al. Radiation Dosimetry and Biodistribution of (68)Ga-FAPI-46 PET Imaging in Cancer Patients. J Nucl Med, 2020,61(8):1171\u20131177","journal-title":"J Nucl Med"},{"issue":"13","key":"2740_CR25","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1007\/s00259-021-05475-0","volume":"48","author":"M Sollini","year":"2021","unstructured":"Sollini M, Kirienko M, Gelardi F, et al. State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging, 2021,48(13):4396\u20134414","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"2740_CR26","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, et al. A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts. J Nucl Med, 2018,59(9):1423\u20131429","journal-title":"J Nucl Med"},{"issue":"9","key":"2740_CR27","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, et al. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein. J Nucl Med, 2018,59(9):1415\u20131422","journal-title":"J Nucl Med"},{"issue":"10","key":"2740_CR28","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2741\/4682","volume":"23","author":"P Busek","year":"2018","unstructured":"Busek P, Mateu R, Zubal M, et al. Targeting fibroblast activation protein in cancer\u2013Prospects and caveats. Front Biosci (Landmark Ed), 2018,23(10):1933\u20131968","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"6","key":"2740_CR29","doi-asserted-by":"publisher","first-page":"952","DOI":"10.2967\/jnumed.121.262533","volume":"63","author":"M Xu","year":"2022","unstructured":"Xu M, Zhang P, Ding J, et al. Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy. J Nucl Med, 2022,63(6):952\u2013958","journal-title":"J Nucl Med"},{"issue":"9","key":"2740_CR30","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, et al. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein. J Nucl Med, 2018,59(9):1415\u20131422","journal-title":"J Nucl Med"},{"key":"2740_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/ITT.S291767","volume":"10","author":"R Bughda","year":"2021","unstructured":"Bughda R, Dimou P, D\u2019souza RR, et al. Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma. Immunotargets Ther, 2021,10:313\u2013323","journal-title":"Immunotargets Ther"},{"issue":"3","key":"2740_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00441-016-2467-x","volume":"365","author":"SE Kuzet","year":"2016","unstructured":"Kuzet SE, Gaggioli C. Fibroblast activation in cancer: when seed fertilizes soil. Cell Tissue Res, 2016,365(3):607\u2013619","journal-title":"Cell Tissue Res"},{"key":"2740_CR33","doi-asserted-by":"publisher","first-page":"127846","DOI":"10.1016\/j.bmcl.2021.127846","volume":"37","author":"HJ Jung","year":"2021","unstructured":"Jung HJ, Nam EH, Park JY, et al. Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor. Bioorg Med Chem Lett, 2021,37:127846","journal-title":"Bioorg Med Chem Lett"},{"issue":"13","key":"2740_CR34","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/pros.22847","volume":"74","author":"WN Brennen","year":"2014","unstructured":"Brennen WN, Rosen DM, Chaux A, et al. Pharmacokinetics and toxicology of a fibroblast activation protein (FAP)-activated prodrug in murine xenograft models of human cancer. Prostate, 2014,74(13):1308\u20131319","journal-title":"Prostate"},{"issue":"13","key":"2740_CR35","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1021\/acs.jmedchem.6b01755","volume":"60","author":"LJ Deng","year":"2017","unstructured":"Deng LJ, Wang LH, Peng CK, et al. Fibroblast Activation Protein a Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity. J Med Chem, 2017,60(13):5320\u20135333","journal-title":"J Med Chem"},{"key":"2740_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2014.04.050","volume":"186","author":"R R\u00fcger","year":"2014","unstructured":"R\u00fcger R, Tansi FL, Rabenhold M, et al. In vivo near-infrared fluorescence imaging of FAP-expressing tumors with activatable FAP-targeted, single-chain Fv-immunoliposomes. J Control Release, 2014,186:1\u201310","journal-title":"J Control Release"},{"key":"2740_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.actbio.2017.03.033","volume":"54","author":"F L Tansi","year":"2017","unstructured":"Tansi F L, R\u00fcger R, B\u00f6hm C, et al. Activatable bispecific liposomes bearing fibroblast activation protein directed single chain fragment\/Trastuzumab deliver encapsulated cargo into the nuclei of tumor cells and the tumor microenvironment simultaneously. Acta Biomater, 2017,54:281\u2013293","journal-title":"Acta Biomater"},{"issue":"38","key":"2740_CR38","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1016\/j.vaccine.2016.07.054","volume":"34","author":"Q Xia","year":"2016","unstructured":"Xia Q, Geng F, Zhang FF, et al. Enhancement of fibroblast activation protein \u03b1-based vaccines and adenovirus boost immunity by cyclophosphamide through inhibiting IL-10 expression in 4T1 tumor bearing mice. Vaccine, 2016,34(38):4526\u20134535","journal-title":"Vaccine"},{"issue":"5","key":"2740_CR39","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00262-016-1827-4","volume":"65","author":"Q Xia","year":"2016","unstructured":"Xia Q, Zhang FF, Geng F, et al. Anti-tumor effects of DNA vaccine targeting human fibroblast activation protein a by producing specific immune responses and altering tumor microenvironment in the 4T1 murine breast cancer model. Cancer Immunol Immunother, 2016,65(5):613\u2013624","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"2740_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/08923973.2016.1269337","volume":"39","author":"Q Xia","year":"2017","unstructured":"Xia Q, Geng F, Zhang FF, et al. Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein a-based DNA vaccine in tumor-bearing mice with murine breast carcinoma. Immunopharmacol Immunotoxicol, 2017,39(1):37\u201344","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"2","key":"2740_CR41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","volume":"2","author":"LC Wang","year":"2014","unstructured":"Wang LC, Lo A, Scholler J, et al. Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity. Cancer Immunol Res, 2014,2(2):154\u2013166","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"2740_CR42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.annonc.2020.10.474","volume":"32","author":"S Hiltbrunner","year":"2021","unstructured":"Hiltbrunner S, Britschgi C, Schuberth P, et al. Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial. Ann Oncol, 2021,32(1):120\u2013121","journal-title":"Ann Oncol"},{"issue":"15","key":"2740_CR43","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1074\/jbc.M115.701433","volume":"291","author":"MH Fan","year":"2016","unstructured":"Fan MH, Zhu Q, Li HH, et al. Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice. J Biol Chem, 2016,291(15):8070\u20138089","journal-title":"J Biol Chem"},{"issue":"10","key":"2740_CR44","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.molmet.2016.07.003","volume":"5","author":"MA S\u00e1nchez-Garrido","year":"2016","unstructured":"S\u00e1nchez-Garrido MA, Habegger KM, Clemmensen C, et al. Fibroblast activation protein (FAP) as a novel metabolic target. Mol Metab, 2016,5(10):1015\u20131024","journal-title":"Mol Metab"},{"issue":"14","key":"2740_CR45","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","volume":"76","author":"X Yang","year":"2016","unstructured":"Yang X, Lin Y, Shi Y, et al. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling. Cancer Res, 2016,76(14):4124\u20134135","journal-title":"Cancer Res"},{"issue":"3","key":"2740_CR46","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","volume":"60","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Kratochwil C, Lindner T, et al. (68)Ga-FAPI PET\/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers. J Nucl Med, 2019,60(3):386\u2013392","journal-title":"J Nucl Med"},{"issue":"1","key":"2740_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41181-021-00144-x","volume":"6","author":"T Lindner","year":"2021","unstructured":"Lindner T, Altmann A, Giesel F, et al. (18)F-labeled tracers targeting fibroblast activation protein. EJNMMI Radiopharm Chem, 2021,6(1):26","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"5","key":"2740_CR48","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10585-015-9723-4","volume":"32","author":"SK Baird","year":"2015","unstructured":"Baird SK, Allan L, Renner C, et al. Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways. Clin Exp Metastasis, 2015,32(5):507\u2013516","journal-title":"Clin Exp Metastasis"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-023-2740-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-023-2740-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-023-2740-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T07:09:12Z","timestamp":1702451352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-023-2740-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["2740"],"URL":"https:\/\/doi.org\/10.1007\/s11596-023-2740-7","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"assertion":[{"value":"12 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}